Possibia

6339138

Last Update Posted: 2024-12-30

Recruiting has ended

All Genders

accepted

18 Years +

589 Estimated Participants

No Expanded Access

Observational Study

Accepts healthy volunteers

Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing in Blood and Urine, the INQUIRE Study

This study is being done to collect blood, tissue and urine samples to identify a novel high quality methylated DNA marker in patients with renal tumors.

PRIMARY OBJECTIVES:

I. In tissue, to discover and validate DNA methylation markers (MDMs) for detection of malignant renal and urothelial tumors.

II. In blood, to assess the accuracy of candidate MDMs from above for detection of malignant renal and urothelial tumors.

OUTLINE: This is an observational study.

Participants may undergo blood, urine, and tissue sample collection on study. Participants' medical records are also reviewed.

Eligibility

Relevant conditions:

Chromophobe Renal Cell Carcinoma

Clear Cell Papillary Renal Tumor

Clear Cell Renal Cell Carcinoma

Kidney Oncocytoma

Papillary Renal Cell Carcinoma

Urothelial Carcinoma

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov